Neogen Corporation
General ticker "NEOG" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.9B (TTM average)
Neogen Corporation follows the US Stock Market performance with the rate: 2.0%.
Estimated limits based on current volatility of 2.0%: low 5.35$, high 5.68$
Factors to consider:
- US accounted for 50.3% of revenue in the fiscal year ended 2024-05-31
- Current price 48.2% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-05-31 to 2026-05-31
- 2024-05-31 to 2025-05-31 estimated range: [10.59$, 18.23$]
- 2025-05-31 to 2026-05-31 estimated range: [10.01$, 17.60$]
Financial Metrics affecting the NEOG estimates:
- Positive: 0.04 < Non-GAAP EPS, $ of 0.44
- Negative: Operating cash flow per share per price, % of 1.28 <= 1.79
- Negative: Industry earnings per price (median), % of -8.94 <= 0
- Positive: -1.21 < Return on assets ratio (scaled to [-100,100]) of -0.21
- Positive: Interest expense per share, $ of 0.34 <= 0.67
- Positive: Industry inventory ratio change (median), % of -0.86 <= -0.28
- Positive: Shareholder equity ratio, % of 69.12 > 63.75
- Positive: -0.87 < Investing cash flow per share, $ of -0.14
Short-term NEOG quotes
Long-term NEOG plot with estimates
Financial data
| YTD | 2022-05-31 | 2023-05-31 | 2024-05-31 |
|---|---|---|---|
| Operating Revenue | $527.16MM | $822.45MM | $924.22MM |
| Operating Expenses | $468.54MM | $784.93MM | $865.56MM |
| Operating Income | $58.62MM | $37.52MM | $58.66MM |
| Non-Operating Income | $1.59MM | $-59.56MM | $-72.97MM |
| Interest Expense | $0.00MM | $55.96MM | $73.39MM |
| R&D Expense | $17.05MM | $26.04MM | $22.48MM |
| Income(Loss) | $60.21MM | $-22.04MM | $-14.30MM |
| Taxes | $11.90MM | $0.83MM | $-4.88MM |
| Profit(Loss)* | $48.31MM | $-22.87MM | $-9.42MM |
| Stockholders Equity | $887.37MM | $3,134.22MM | $3,144.14MM |
| Inventory | $122.31MM | $133.81MM | $189.27MM |
| Assets | $992.93MM | $4,554.43MM | $4,548.83MM |
| Operating Cash Flow | $68.04MM | $41.03MM | $35.26MM |
| Capital expenditure | $24.43MM | $65.76MM | $111.42MM |
| Investing Cash Flow | $-97.23MM | $201.04MM | $-29.31MM |
| Financing Cash Flow | $6.81MM | $-118.08MM | $1.92MM |
| Earnings Per Share** | $0.45 | $-0.12 | $-0.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.